Olivier Masson

408 total citations
9 papers, 326 citations indexed

About

Olivier Masson is a scholar working on Immunology and Allergy, Cancer Research and Oncology. According to data from OpenAlex, Olivier Masson has authored 9 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology and Allergy, 5 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Olivier Masson's work include Cell Adhesion Molecules Research (5 papers), Protease and Inhibitor Mechanisms (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). Olivier Masson is often cited by papers focused on Cell Adhesion Molecules Research (5 papers), Protease and Inhibitor Mechanisms (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). Olivier Masson collaborates with scholars based in France, Canada and United States. Olivier Masson's co-authors include Emmanuelle Liaudet‐Coopman, Christine Prébois, Danielle Derocq, Valérie Laurent‐Matha, Sophie Pattingre, Didier Quilliot, Cédric Dray, Catherine Muller, Philippe Valet and Aline Meulle and has published in prestigious journals such as PLoS ONE, Oncogene and The FASEB Journal.

In The Last Decade

Olivier Masson

9 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olivier Masson France 8 147 114 82 56 48 9 326
Gregory Miles United States 5 199 1.4× 117 1.0× 88 1.1× 53 0.9× 30 0.6× 5 345
Nicole Malet France 13 275 1.9× 71 0.6× 71 0.9× 56 1.0× 37 0.8× 17 507
Hyoung‐Tae An South Korea 13 231 1.6× 66 0.6× 44 0.5× 78 1.4× 44 0.9× 16 365
Agnese Di Rocco United States 12 282 1.9× 105 0.9× 115 1.4× 39 0.7× 29 0.6× 13 447
Hyun-Jin Shin South Korea 9 286 1.9× 82 0.7× 101 1.2× 119 2.1× 46 1.0× 13 446
Takenori Fujii Japan 11 193 1.3× 63 0.6× 83 1.0× 48 0.9× 37 0.8× 22 347
Xingning Lai China 9 233 1.6× 149 1.3× 39 0.5× 30 0.5× 24 0.5× 12 376
Liyu Wu United States 6 354 2.4× 81 0.7× 121 1.5× 24 0.4× 20 0.4× 8 451
Song-Ping Li Finland 4 229 1.6× 122 1.1× 91 1.1× 46 0.8× 10 0.2× 5 394
Jinping Li China 10 261 1.8× 164 1.4× 69 0.8× 68 1.2× 16 0.3× 17 396

Countries citing papers authored by Olivier Masson

Since Specialization
Citations

This map shows the geographic impact of Olivier Masson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Masson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Masson more than expected).

Fields of papers citing papers by Olivier Masson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier Masson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Masson. The network helps show where Olivier Masson may publish in the future.

Co-authorship network of co-authors of Olivier Masson

This figure shows the co-authorship network connecting the top 25 collaborators of Olivier Masson. A scholar is included among the top collaborators of Olivier Masson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivier Masson. Olivier Masson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Yoo, Byong Hoon, Olivier Masson, Alexi P. Surette, et al.. (2018). ErbB2-driven downregulation of the transcription factor Irf6 in breast epithelial cells is required for their 3D growth. Breast Cancer Research. 20(1). 151–151. 11 indexed citations
2.
Yoo, Byounghyun, Olivier Masson, Dale Corkery, et al.. (2016). ErbB2-dependent downregulation of a pro-apoptotic protein Perp is required for oncogenic transformation of breast epithelial cells. Oncogene. 35(44). 5759–5769. 19 indexed citations
3.
Rosen, Kirill V., et al.. (2014). 105: Anoikis of colon carcinoma cells triggered by beta-catenin loss can be enhanced by Tumor Necrosis Factor Receptor 1 antagonists. European Journal of Cancer. 50. S24–S24. 1 indexed citations
4.
Yoo, Byounghyun, et al.. (2014). Anoikis of colon carcinoma cells triggered by β-catenin loss can be enhanced by tumor necrosis factor receptor 1 antagonists. Oncogene. 34(38). 4939–4951. 10 indexed citations
5.
Laurent‐Matha, Valérie, Pitter F. Huesgen, Olivier Masson, et al.. (2012). Proteolysis of cystatin C by cathepsin D in the breast cancer microenvironment. The FASEB Journal. 26(12). 5172–5181. 55 indexed citations
6.
Masson, Olivier, Christine Prébois, Danielle Derocq, et al.. (2011). Cathepsin-D, a Key Protease in Breast Cancer, Is Up-Regulated in Obese Mouse and Human Adipose Tissue, and Controls Adipogenesis. PLoS ONE. 6(2). e16452–e16452. 53 indexed citations
7.
Masson, Olivier, Danielle Derocq, Christine Prébois, et al.. (2010). Pathophysiological functions of cathepsin D: Targeting its catalytic activity versus its protein binding activity?. Biochimie. 92(11). 1635–1643. 75 indexed citations
8.
Beaujouin, Mélanie, Christine Prébois, Danielle Derocq, et al.. (2010). Pro-cathepsin D interacts with the extracellular domain of the β chain of LRP1 and promotes LRP1-dependent fibroblast outgrowth. Journal of Cell Science. 123(19). 3336–3346. 50 indexed citations
9.
Masson, Olivier, Carine Chavey, Cédric Dray, et al.. (2009). LRP1 Receptor Controls Adipogenesis and Is Up-Regulated In Human and Mouse Obese Adipose Tissue. PLoS ONE. 4(10). e7422–e7422. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026